 role intraluminal radiotherapy concurrent infusion management carcinoma esophagus pilot study Fifty patients carcinoma esophagus randomized pilot study efficacy intraluminal radiotherapy ILRT concurrent infusion median age years middle third lesions lesions cm external beam therapy Gy weeks patients chemotherapy Significant improvement dysphagia patients complete response cases months overall survival years ILRT ILRT infusion